Portfolio Update Sold 1/2 $LPCN 7.64 from $8.32 average taking a 8% loss on half here, it's been a rough trade, happy to sell into today's strength. I lean towards approval, but that is a "lean" could go either way, I would feel a lot more comfortable with a bit more data on patients that were on the higher side of T concentration, over 1800. AE's were low and in expectation range, but I would like to know AE's and blood data on those in the trial cmax concentration of 1800. Without that data it's hard to call.
-BioHunter
Twitter: @TheBio_Hunter